Carlyle Group Inc.

Carlyle Group Inc. reported 19 holdings worth US$10B as of Jun 30, 2026 (Form 13F)

As of Jun 30, 2026 · Filed Aug 7, 2026

Carlyle Group Inc. reported 19 holdings worth US$10B as of Jun 30, 2026. Largest: Medline Inc., Standardaero, Inc. and Phathom Pharmaceuticals, Inc. Filed Aug 7, 2026 (Form 13F).

Holdings
19
Value as reported
US$10B

The filing in full

CompanySharesValue as reported% of portfolio
Medline Inc.187MUS$7.38B73.8%
Standardaero, Inc.84.6MUS$2.53B25.3%
Phathom Pharmaceuticals, Inc.3.5MUS$37.9M0.38%
Invitation Homes Inc.663KUS$20M0.20%
Pony Ai Inc. Class A2.36MUS$16.4M0.16%
Getty Images Holdings, Inc.6.23MUS$5.36M0.05%
Spruce Biosciences, Inc.38,620US$2.09M0.02%
Sunpower Inc.2.34MUS$1.61M0.02%
Adicet Bio, Inc.184KUS$1.59M0.02%
Forward Air Corporation107KUS$1.45M0.01%
Onkure Therapeutics, Inc.270KUS$1.23M0.01%
Krispy Kreme, Inc.341KUS$1.2M0.01%
Q32 Bio Inc.60,363US$769K<0.01%
Riley Exploration Permian, Inc.16,092US$530K<0.01%
Robinhood Markets, Inc.4,733US$475K<0.01%
Jasper Therapeutics, Inc.1.07MUS$449K<0.01%
N-able, Inc.93,732US$344K<0.01%
Ramaco Resources, Inc.21,743US$288K<0.01%
Cubesmart0US$00.00%
Exicure, Inc.0US$00.00%
Heartflow, Inc.0US$00.00%
Spyre Therapeutics, Inc.0US$00.00%

Source

View original at SEC

Related